Pardis Roozkhosh | additive manufacturing | Best Researcher Award

Posted on by sciencefather

Dr. Pardis Roozkhosh | additive manufacturing | Best Researcher Award

Lecturer, Ferdowsi University of Mashhad, Iran

🎓 Pardis Roozkhosh is a dedicated researcher and academic currently affiliated with the Economic and Administrative Sciences Faculty at Ferdowsi University of Mashhad, Iran. Her work spans the intersection of management science, optimization models, and data-driven decision-making. Pardis is passionate about developing innovative solutions for complex engineering and management problems, contributing significantly to the fields of system assurance and financial prediction. 📚✨

Publication Profile

Scopus

Education

🎓 Pardis Roozkhosh has been pursuing her academic journey at Ferdowsi University of Mashhad since June 2019. She is part of the Economic and Administrative Sciences Faculty, focusing her expertise on research-driven methodologies to address real-world challenges.

Experience

🌟 Pardis has actively contributed to the academic community through her research publications and peer review activities. She is recognized for her insightful contributions to journals such as the International Journal of System Assurance Engineering and Management and Applied Soft Computing. Her expertise includes optimization models, decision-making under uncertainty, and financial predictions.

Research Interests

💡 Pardis Roozkhosh’s research interests include multi-criteria decision-making (MCDM), optimization in management science, hub location-allocation problems, and predictive modeling for financial systems like Bitcoin price forecasting. Her work is deeply rooted in addressing uncertainty and tardiness in real-world scenarios. 🔍📈

Awards

🏆 While specific awards are not listed, Pardis’s impactful publications and active contributions to peer reviews in renowned journals like Expert Systems with Applications reflect her professional recognition in the academic community.

Publications

A new model to design a product under redundancy allocation problem and MCDM
📅 Published: November 29, 2024 | Journal: International Journal of System Assurance Engineering and Management
📖 Cited by: Pending

Designing a new model for the hub location-allocation problem with considering tardiness time and cost uncertainty
📅 Published: January 2, 2023 | Journal: International Journal of Management Science and Engineering Management
📖 Cited by: Pending

MLP-based Learnable Window Size for Bitcoin price prediction
📅 Published: August 2022 | Journal: Applied Soft Computing
📖 Cited by: Part of ISSN: 1568-4946

Designing a new model for the hub location-allocation problem with considering tardiness time and cost uncertainty
📅 Published: June 5, 2022 | Journal: International Journal of Management Science and Engineering Management
📖 Cited by: Pending

 

 

Mohammad Akrami | Additive manufacturing | Excellence in Innovation

Posted on by sciencefather

Assist Prof Dr. Mohammad Akrami | Additive manufacturing | Excellence in Innovation

Faculty of Pharmacy, Tehran University of Medical Sciences, Iran

Dr. Mohammad Akrami is an Assistant Professor at the Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS) 🎓. He is actively engaged in teaching and research, focusing on advanced drug delivery systems, bioprinting, and nanotechnology 🧪. In addition to his academic roles, Dr. Akrami contributes to pharmaceutical development as a chairman and consultant for various pharmaceutical companies 💼.

Publication Profile

ORCID

Strengths for the Award

Dr. Mohammad Akrami’s background highlights several strengths that align well with the Research for Excellence in Innovation award criteria:

  1. Pioneering Research: Dr. Akrami’s work on drug delivery systems, such as 3D pharming, 3D bioprinting, nanoghost fabrication, and cancer-targeting methods, places him at the forefront of pharmaceutical innovation.
  2. Publications: He has contributed significantly to the scientific community, with multiple peer-reviewed publications in high-impact journals like Scientific Reports and European Journal of Pharmaceutical Sciences. These papers focus on cutting-edge research, including nanoparticle-based drug delivery systems and cancer therapy.
  3. Cross-disciplinary Expertise: His expertise spans several crucial fields, such as nanomedicine, diagnostic kit development, and analytical techniques, which could be seen as a significant asset for this innovation award.
  4. Leadership and Mentorship: As an assistant professor and chairperson in various institutions, Dr. Akrami has taken leadership roles, indicating his influence in nurturing new talent and promoting innovation in the academic and pharmaceutical sectors.
  5. Industry & Government Engagement: His contributions to productivity and entrepreneurship in medical education and collaboration with the Ministry of Health on knowledge-based businesses show that he plays a crucial role in applying research for societal benefit.

Areas for Improvement

  1. International Collaborations: While his work in Iran is highly impactful, expanding collaborative projects or joint publications with international researchers would enhance the global visibility of his innovative research.
  2. Diversification of Research Funding: Securing international grants and partnerships could further boost his ability to innovate at a larger scale, especially in highly competitive pharmaceutical and nanotechnology fields.
  3. Impact of Research Applications: Emphasizing practical real-world implementations of his research in terms of commercial products or clinical applications could strengthen the case for excellence in innovation.

Education:

Dr. Akrami holds a PhD from Tehran University of Medical Sciences 🏛️, specializing in Pharmaceutical Biomaterials. His PhD thesis explored peptide-functionalized gold nanoparticles for breast cancer therapy 🧬. He also completed his M.Sc. in Biological Sciences at Tarbiat Modares University, where his thesis focused on plasminogen activation and its role in fibrinolytic systems 🩺.

Experience:

Dr. Akrami has vast experience in both academia and industry 🏢. He has served as R&D Head, Consultant, and Expert in the pharmaceutical sector, particularly at SOHA Pharmaceutical Company. His expertise spans solid and semi-solid pharmaceutical formulations, diagnostic kit development, and nanoparticle-based drug delivery 🚀. He is also the Chairman of the Board at Zist Mavad Pharmed Co. and has contributed to the Ministry of Health’s working groups on entrepreneurship and knowledge-based businesses 📊.

Research Focus:

Dr. Akrami’s research primarily focuses on innovative drug delivery systems and cancer therapy 🎯. His key interests include 3D pharming, nanoghost fabrication, microbubble-based drug delivery, and cancer targeting technologies 💉. His work on peptide-functionalized gold nanoparticles has made significant strides in breast cancer treatment 🏆.

Awards and Honours:

Dr. Akrami was recognized at the 24th Shahid Motahari Festival at Tehran University of Medical Sciences in 2023 for his outstanding contributions to pharmaceutical sciences 🎖️.

Publication Top Notes:

Dr. Akrami has authored numerous peer-reviewed articles on drug delivery and nanoparticle technologies. Below are some of his prominent publications:

Evaluation of multilayer coated magnetic nanoparticles as biocompatible curcumin delivery platforms for breast cancer treatment, RSC Adv., 2015. Cited by 50 articles. RSC Adv. 2015

Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms, Sci. Rep., 2016. Cited by 75 articles. Sci. Rep. 2016

Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review, Colloids and Surfaces B: Biointerfaces, 2017. Cited by 43 articles. Colloids and Surfaces B 2017

Glutathione Conjugated Polyethylenimine on the Surface of Fe3O4 Magnetic Nanoparticles as a Theranostic Agent, Journal of Biomaterials Science, Polymer Edition, 2018. Cited by 34 articles. Journal of Biomaterials Science 2018

Curcumin-lipoic acid conjugate as a promising anticancer agent on the surface of gold-iron oxide nanocomposites, European Journal of Pharmaceutical Sciences, 2018. Cited by 60 articles. European Journal of Pharmaceutical Sciences 2018

The potentials of antiplasminogen monoclonal antibodies in fibrinolytic & angiogenesis system manipulation, Tehran University of Medical Sciences, 2009. Cited by 28 articles. Tehran University 2009

Conclusion

Dr. Mohammad Akrami’s research in advanced pharmaceutical biomaterials and drug delivery systems, combined with his strong academic and professional leadership, positions him as a strong candidate for the Research for Excellence in Innovation award. With a proven track record in groundbreaking research, particularly in cancer therapies and nanotechnology, and a solid portfolio of publications and professional contributions, he demonstrates the qualities sought for this recognition. Expanding his international engagement and funding sources could further elevate his profile.